News Releases
Jan 5, 2024

Presentation by CEO Mark Engel Highlighting both Platform and Product Pipeline Advances DOVER, Del., Jan. 5, 2024 /PRNewswire/ -- Precisio Biotix today announced that it is presenting at both the...

Jan 4, 2024

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that...

Jan 4, 2024

Halia Therapeutics, a clinical-stage biopharmaceutical company, is pioneering a novel class of small molecule medications designed to combat inflammation. Today, the company announced that its...

Jan 2, 2024

Biotech Showcase coincides with the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco January 8-11, 2024 IRVINE, Calif., Jan. 2, 2024 /PRNewswire/ -- VESICA HEALTH, INC., a...

Jan 2, 2024

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that Dr. Hai Wu, R&D VP of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present...

More »